Bank of America’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-45,000
| Closed | -$3.82M | – | 7582 |
|
|
2019
Q4 | $3.82M | Buy |
45,000
+9,600
| +27% | +$640K | ﹤0.01% | 3485 |
|
|
2019
Q3 | $1.77M | Buy |
35,400
+33,600
| +1,867% | +$1.34M | ﹤0.01% | 4153 |
|
|
2019
Q2 | $66K | Sell |
1,800
-33,900
| -95% | -$1.11M | ﹤0.01% | 6192 |
|
|
2019
Q1 | $998K | Hold |
35,700
| – | – | ﹤0.01% | 4519 |
|
|
2018
Q4 | $683K | Sell |
35,700
-6,800
| -16% | -$158K | ﹤0.01% | 4708 |
|
|
2018
Q3 | $1.27M | Hold |
42,500
| – | – | ﹤0.01% | 4324 |
|
|
2018
Q2 | $1.56M | Hold |
42,500
| – | – | ﹤0.01% | 4164 |
|
|
2018
Q1 | $1.4M | Sell |
42,500
-75,400
| -64% | -$2.36M | ﹤0.01% | 4148 |
|
|
2017
Q4 | $3.22M | Sell |
117,900
-7,100
| -6% | -$219K | ﹤0.01% | 3530 |
|
|
2017
Q3 | $4.63M | Buy |
125,000
+50,000
| +67% | +$1.84M | ﹤0.01% | 3251 |
|
|
2017
Q2 | $2.85M | Hold |
75,000
| – | – | ﹤0.01% | 3565 |
|
|
2017
Q1 | $3.67M | Buy |
75,000
+12,000
| +19% | +$547K | ﹤0.01% | 3323 |
|
|
2016
Q4 | $2.14M | Buy |
63,000
+18,000
| +40% | +$638K | ﹤0.01% | 3719 |
|
|
2016
Q3 | $1.7M | Buy |
+45,000
| New | +$1.7M | ﹤0.01% | 3774 |
|
|
2016
Q2 | – | Sell |
-248,400
| Closed | -$7.89M | – | 7538 |
|
|
2016
Q1 | $7.89M | Buy |
248,400
+187,500
| +308% | +$6.12M | ﹤0.01% | 2363 |
|
|
2015
Q4 | $2.27M | Buy |
60,900
+22,700
| +59% | +$858K | ﹤0.01% | 3693 |
|
|
2015
Q3 | $1.45M | Buy |
38,200
+12,000
| +46% | +$421K | ﹤0.01% | 4051 |
|
|
2015
Q2 | $750K | Sell |
26,200
-1,400
| -5% | -$39K | ﹤0.01% | 4361 |
|
|
2015
Q1 | $773K | Buy |
+27,600
| New | +$775K | ﹤0.01% | 3966 |
|
Other funds holding MDCO
Bank of America's MDCO Position: Q1 2020 in Review
Bank of America sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,220,832 shares — an estimated $104M sold.
Bank of America first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $104M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Bank of America reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Bank of America sold 1,220,832 Medicines Co shares in Q1 2020, an estimated $104M.
- Bank of America first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Bank of America's Medicines Co position peaked at $104M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Bank of America's 13F filing for Q1 2020, filed 15 May 2020.